Clinical outcomes after relapse during rituximab-based maintenance in ANCA-associated vasculitis: A single-center retrospective cohort study. (PubMed, PLoS One) - Sep 16, 2026 - "Mycophenolate mofetil (MMF) has been investigated as an alternative; however, evidence regarding its use after relapse during RTX-based maintenance is limited. Because treatment allocation was non-randomized and post-relapse treatment strategies differed with respect to RTX scheduling, concomitant therapies, and physician-directed glucocorticoid tapering, the independent effect of MMF could not be determined. Therefore, these descriptive and hypothesis-generating findings warrant confirmation in future prospective studies."
Clinical data • Journal • Retrospective data • ANCA Vasculitis • Infectious Disease • Vasculitis
|
|
Genri Tagami; Hirokazu Sugiyama; Hiroshi Kinashi; Keisuke Kamiya; Makoto Yamaguchi; Masayoshi Toda; Shogo Banno; Takahiro Imaizumi; Takayuki Katsuno; Takuji Ishimoto; Yasuhiko Ito
|